Lung Cancer
Volume 69, Issue 1 , Pages 40-45 , July 2010

Pathological confirmation of primary lung cancer following breast cancer

  • M. Tennis

      Affiliations

    • Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, United States
    • Corresponding Author InformationCorresponding author at: University of Colorado Denver Health Science Center, Division of Pulmonary and Critical Care, 12700 E 19th Ave, Box C272, Aurora, CO 80045, United States. Tel.: +303 724 7093; fax: +303 724 6042.
    • ,
  • B. Singh

      Affiliations

    • New York Medical University Medical Center, New York, NY, United States
    • ,
  • A. Hjerpe

      Affiliations

    • Karolinska Institutet, Stockholm, Sweden
    • ,
  • M. Prochazka

      Affiliations

    • Karolinska Institutet, Stockholm, Sweden
    • ,
  • K. Czene

      Affiliations

    • Karolinska Institutet, Stockholm, Sweden
    • ,
  • P. Hall

      Affiliations

    • Karolinska Institutet, Stockholm, Sweden
    • ,
  • P.G. Shields

      Affiliations

    • Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, United States

Received 28 January 2009 ,Revised 17 July 2009 ,Accepted 20 August 2009.

References 

  1. Wilkins KL, Woodgate RL. Preventing second cancers in cancer survivors. Oncol Nurs Forum. 2008;35:E12–22
  2. Desandes E, Berger C, Tron I, Demeocq F, Bellec S, Blouin P, et al. Childhood cancer survival in France, 1990–1999. Eur J Cancer. 2008;44:205–215
  3. Zhou CX, Gao Y. Frequent genetic alterations and reduced expression of the Axin1 gene in oral squamous cell carcinoma: involvement in tumor progression and metastasis. Oncol Rep. 2007;17:73–79
  4. Matesich SM, Shapiro CL. Second cancers after breast cancer treatment. Semin Oncol. 2003;30:740–748
  5. Dawood S, Broglio K, Esteva FJ, Ibrahim NK, Kau SW, Islam R, et al. Defining prognosis for women with breast cancer and CNS metastases by HER2 status. Ann Oncol. 2008;
  6. Kirova YM, Gambotti L, De Rycke Y, Vilcoq JR, Asselain B, Fourquet A. Risk of second malignancies after adjuvant radiotherapy for breast cancer: a large-scale, single-institution review. Int J Radiat Oncol Biol Phys. 2007;68:359–363
  7. Hemminki K, Zhang H, Sundquist J, Lorenzo Bermejo J. Modification of risk for subsequent cancer after female breast cancer by a family history of breast cancer. Breast Cancer Res Treat. 2007;
  8. Park SM, Lim MK, Jung KW, Shin SA, Yoo KY, Yun YH, et al. Prediagnosis smoking, obesity, insulin resistance, and second primary cancer risk in male cancer survivors: National Health Insurance Corporation Study. J Clin Oncol. 2007;25:4835–4843
  9. Soliman H, Agresta SV. Current issues in adolescent and young adult cancer survivorship. Cancer Control. 2008;15:55–62
  10. Evans HS, Lewis CM, Robinson D, Bell CM, Moller H, Hodgson SV. Incidence of multiple primary cancers in a cohort of women diagnosed with breast cancer in southeast England. Br J Cancer. 2001;84:435–440
  11. Levi F, Te VC, Randimbison L, La Vecchia C. Cancer risk in women with previous breast cancer. Ann Oncol. 2003;14:71–73
  12. Volk N, Pompe-Kirn V. Second primary cancers in breast cancer patients in Slovenia. Cancer Causes Control. 1997;8:764–770
  13. Soerjomataram I, Louwman WJ, de Vries E, Lemmens VE, Klokman WJ, Coebergh JW. Primary malignancy after primary female breast cancer in the South of the Netherlands, 1972–2001. Breast Cancer Res Treat. 2005;93:91–95
  14. Mellemkjaer L, Friis S, Olsen JH, Scelo G, Hemminki K, Tracey E, et al. Risk of second cancer among women with breast cancer. Int J Cancer. 2006;118:2285–2292
  15. Tanaka H, Tsukuma H, Koyama H, Kinoshita Y, Kinoshita N, Oshima A. Second primary cancers following breast cancer in the Japanese female population. Jpn J Cancer Res. 2001;92:1–8
  16. Prochazka M, Granath F, Ekbom A, Shields PG, Hall P. Lung cancer risks in women with previous breast cancer. Eur J Cancer. 2002;38:1520–1525
  17. Kaufman EL, Jacobson JS, Hershman DL, Desai M, Neugut AI. Effect of breast cancer radiotherapy and cigarette smoking on risk of second primary lung cancer. J Clin Oncol. 2008;26:392–398
  18. Prochazka M, Hall P, Gagliardi G, Granath F, Nilsson BN, Shields PG, et al. Ionizing radiation and tobacco use increases the risk of a subsequent lung carcinoma in women with breast cancer: case-only design. J Clin Oncol. 2005;23:7467–7474
  19. Neugut AI, Murray T, Santos J, Amols H, Hayes MK, Flannery JT, et al. Increased risk of lung cancer after breast cancer radiation therapy in cigarette smokers. Cancer. 1994;73:1615–1620
  20. Inskip PD, Stovall M, Flannery JT. Lung cancer risk and radiation dose among women treated for breast cancer. J Natl Cancer Inst. 1994;86:983–988
  21. Inskip PD. Second cancers following radiotherapy. In:  Neugut AIM editors. Multiple Primary Cancers. Philadelphia: Lippincott Williams & Wilkins; 1999;pp. 91–135
  22. Deutsch M, Land SR, Begovic M, Wieand HS, Wolmark N, Fisher B. The incidence of lung carcinoma after surgery for breast carcinoma with and without postoperative radiotherapy. Results of National Surgical Adjuvant Breast and Bowel Project (NSABP) clinical trials B-04 and B-06. Cancer. 2003;98:1362–1368
  23. Dennis JL, Hvidsten TR, Wit EC, Komorowski J, Bell AK, Downie I, et al. Markers of adenocarcinoma characteristic of the site of origin: development of a diagnostic algorithm. Clin Cancer Res. 2005;11:3766–3772
  24. Moldvay J, Jackel M, Bogos K, Soltesz I, Agocs L, Kovacs G, et al. The role of TTF-1 in differentiating primary and metastatic lung adenocarcinomas. Pathol Oncol Res. 2004;10:85–88
  25. Chang YL, Lee YC, Liao WY, Wu CT. The utility and limitation of thyroid transcription factor-1 protein in primary and metastatic pulmonary neoplasms. Lung Cancer. 2004;44:149–157
  26. Zamecnik J, Kodet R. Value of thyroid transcription factor-1 and surfactant apoprotein A in the differential diagnosis of pulmonary carcinomas: a study of 109 cases. Virchows Arch. 2002;440:353–361
  27. Jan IS, Chung PF, Weng MH, Huang MS, Lee YT, Kuo SH. Utility of thyroid transcription factor-1 expression in the differential diagnosis of metastatic adenocarcinoma of serous effusion specimens prepared using the cell transfer technique. J Formos Med Assoc. 2006;105:695–700
  28. Su YC, Hsu YC, Chai CY. Role of TTF-1, CK20, and CK7 immunohistochemistry for diagnosis of primary and secondary lung adenocarcinoma. Kaohsiung J Med Sci. 2006;22:14–19
  29. Kayser K, Biechele U, Kayser G, Dienemann H, Andre S, Bovin NV, et al. Pulmonary metastases of breast carcinomas: ligandohistochemical, nuclear, and structural analysis of primary and metastatic tumors with emphasis on period of occurrence of metastases and survival. J Surg Oncol. 1998;69:137–146
  30. Umekita Y, Sagara Y, Yoshida H. Estrogen receptor mutations and changes in estrogen receptor and progesterone receptor protein expression in metastatic or recurrent breast cancer. Jpn J Cancer Res. 1998;89:27–32
  31. Lower EE, Glass EL, Bradley DA, Blau R, Heffelfinger S. Impact of metastatic estrogen receptor and progesterone receptor status on survival. Breast Cancer Res Treat. 2005;90:65–70
  32. Koda M, Sulkowski S, Kanczuga-Koda L, Surmacz E, Sulkowska M. Expression of ERalpha, ERbeta and Ki-67 in primary tumors and lymph node metastases in breast cancer. Oncol Rep. 2004;11:753–759
  33. Allred DC, Harvey JM, Berardo M, Clark GM. Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Mod Pathol. 1998;11:155–168
  34. Brenner DJ, Hall EJ, Curtis RE, Ron E. Prostate radiotherapy is associated with second cancers in many organs, not just the colorectum. Gastroenterology. 2005;129:773–774author reply 774–775
  35. Bassal M, Mertens AC, Taylor L, Neglia JP, Greffe BS, Hammond S, et al. Risk of selected subsequent carcinomas in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. J Clin Oncol. 2006;24:476–483
  36. Tucker MA, Murray N, Shaw EG, Ettinger DS, Mabry M, Huber MH, et al. Second primary cancers related to smoking and treatment of small-cell lung cancer. Lung Cancer Working Cadre. J Natl Cancer Inst. 1997;89:1782–1788
  37. Chang EY, Johnson W, Karamlou K, Khaki A, Komanapalli C, Walts D, et al. The evaluation and treatment implications of isolated pulmonary nodules in patients with a recent history of breast cancer. Am J Surg. 2006;191:641–645
  38. Ford MB, Sigurdson AJ, Petrulis ES, Ng CS, Kemp B, Cooksley C, et al. Effects of smoking and radiotherapy on lung carcinoma in breast carcinoma survivors. Cancer. 2003;98:1457–1464

PII: S0169-5002(09)00482-6

doi: 10.1016/j.lungcan.2009.08.018

Lung Cancer
Volume 69, Issue 1 , Pages 40-45 , July 2010

Article Tools

* Image Usage & Resolution